Published in World J Gastroenterol on April 14, 2014
N3 subclassification incorporated into the final pathologic staging of gastric cancer: a modified system based on current AJCC staging. Medicine (Baltimore) (2015) 0.94
NAIF1 inhibits gastric cancer cells migration and invasion via the MAPK pathways. J Cancer Res Clin Oncol (2014) 0.84
Epstein-Barr virus latent membrane protein 2A suppresses the expression of HER2 via a pathway involving TWIST and YB-1 in Epstein-Barr virus-associated gastric carcinomas. Oncotarget (2015) 0.81
Comparison of laparoscopic versus open gastrectomy for advanced gastric cancer: an updated meta-analysis. Gastric Cancer (2015) 0.80
Loss of PCDH9 is associated with the differentiation of tumor cells and metastasis and predicts poor survival in gastric cancer. Clin Exp Metastasis (2015) 0.80
Clinical significance of lymphadenectomy in patients with gastric cancer. World J Gastrointest Oncol (2016) 0.79
The Impact of Confluence Types of the Right Gastroepiploic Vein on No. 6 Lymphadenectomy During Laparoscopic Radical Gastrectomy. Medicine (Baltimore) (2015) 0.79
Lymph node status after resection for gallbladder adenocarcinoma: prognostic implications of different nodal staging/scoring systems. J Surg Oncol (2014) 0.78
CXCL1 expression is correlated with Snail expression and affects the prognosis of patients with gastric cancer. Oncol Lett (2015) 0.78
Increased number of negative lymph nodes is associated with improved survival outcome in node positive gastric cancer following radical gastrectomy. Oncotarget (2016) 0.78
Primo Vascular System: An Endothelial-to-Mesenchymal Potential Transitional Tissue Involved in Gastric Cancer Metastasis. Evid Based Complement Alternat Med (2015) 0.78
Xiaotan Sanjie decoction inhibits interleukin-8-induced metastatic potency in gastric cancer. World J Gastroenterol (2015) 0.78
Low-dose interleukin-8 induces the adhesion, migration and invasion of the gastric cancer SGC-7901 cell line. Oncol Lett (2015) 0.77
Perioperative dynamics and significance of amino acid profiles in patients with cancer. J Transl Med (2015) 0.77
Loss of GFAT1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer. Oncotarget (2016) 0.77
Synergistic combination of DT-13 and topotecan inhibits human gastric cancer via myosin IIA-induced endocytosis of EGF receptor in vitro and in vivo. Oncotarget (2016) 0.76
Interleukin-13 receptor α2 is associated with poor prognosis in patients with gastric cancer after gastrectomy. Oncotarget (2016) 0.75
Quantitative global proteome and lysine succinylome analyses provide insights into metabolic regulation and lymph node metastasis in gastric cancer. Sci Rep (2017) 0.75
A Case of Advanced Gastric Cancer with Para-Aortic Lymph Node Metastasis from Co-Occurring Prostate Cancer. J Gastric Cancer (2017) 0.75
Recurrent amplification of RTEL1 and ABCA13 and its synergistic effect associated with clinicopathological data of gastric adenocarcinoma. Mol Cytogenet (2016) 0.75
Metastasis-associated in colon cancer-1 in gastric cancer: Beyond metastasis. World J Gastroenterol (2016) 0.75
High Hepsin expression predicts poor prognosis in Gastric Cancer. Sci Rep (2016) 0.75
Identification of Biomarkers for Predicting Lymph Node Metastasis of Stomach Cancer Using Clinical DNA Methylation Data. Dis Markers (2017) 0.75
GNB2L1 and its O-GlcNAcylation regulates metastasis via modulating epithelial-mesenchymal transition in the chemoresistance of gastric cancer. PLoS One (2017) 0.75
α-Actinin-4 promotes metastasis in gastric cancer. Lab Invest (2017) 0.75
Gastrokine 1 inhibits gastric cancer cell migration and invasion by downregulating RhoA expression. Gastric Cancer (2016) 0.75
Japanese Classification of Gastric Carcinoma - 2nd English Edition - Gastric Cancer (1998) 16.63
D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med (2008) 9.00
Extended lymph-node dissection for gastric cancer. N Engl J Med (1999) 7.43
Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer (1999) 6.76
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol (2010) 6.60
Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol (2006) 4.38
Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501. J Clin Oncol (2004) 4.31
Cohort study based on the seventh edition of the TNM classification for gastric cancer: proposal of a new staging system. J Clin Oncol (2011) 3.46
Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol (2005) 2.60
Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol (2003) 2.56
Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1. J Clin Oncol (2003) 2.27
Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol (2002) 2.01
New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg (1995) 1.96
Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer (2006) 1.78
Evaluation of the New International Union Against Cancer TNM staging for gastric carcinoma. Cancer (2000) 1.77
Role of the extended lymphadenectomy in gastric cancer surgery: experience in a single institution. Ann Surg Oncol (2003) 1.76
Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer. Br J Surg (2010) 1.69
Superiority of a new UICC-TNM staging system for gastric carcinoma. Surgery (2000) 1.67
Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single center series of 250 patients. J Surg Oncol (2006) 1.60
Lymphadenectomy in gastric carcinoma. A prospective and prognostic study. Arch Surg (1992) 1.53
Comparison of the 6th and 7th editions of the UICC TNM staging system for gastric cancer: results of a Chinese single-institution study of 1,503 patients. Ann Surg Oncol (2010) 1.51
Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol (2004) 1.51
The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients. Ann Surg Oncol (2009) 1.50
Suitability of 7th UICC N stage for predicting the overall survival of gastric cancer patients after curative resection in China. Ann Surg Oncol (2010) 1.47
Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature. Am Surg (2007) 1.47
Risk factors predictive of lymph node metastasis in depressed early gastric cancer. Am J Surg (2002) 1.40
Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann Surg Oncol (2002) 1.40
Prognostic value of the 7th AJCC/UICC TNM classification of noncardia gastric cancer: analysis of a large series from specialized Western centers. Ann Surg (2012) 1.35
Association of VCAM-1 overexpression with oncogenesis, tumor angiogenesis and metastasis of gastric carcinoma. World J Gastroenterol (2003) 1.33
Influence of the number of lymph nodes examined on staging of gastric cancer. Br J Surg (2001) 1.30
Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. Surg Gynecol Obstet (1990) 1.27
Postoperative complications and mortality after surgery for gastric cancer. Ann Surg (1988) 1.26
Status of extended lymph node dissection: locoregional control is the only way to survive gastric cancer. J Surg Oncol (2005) 1.26
Negative lymph node count is associated with survival of colorectal cancer patients, independent of tumoral molecular alterations and lymphocytic reaction. Am J Gastroenterol (2009) 1.26
Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma. Gut (1996) 1.23
Prognostic factors after curative resection for gastric cancer. A population-based study. Eur J Cancer (2000) 1.22
Effect of lymph node number on survival of patients with lymph node-negative gastric cancer according to the 7th edition UICC TNM system. PLoS One (2012) 1.20
Early gastric cancer: prognostic factors in 223 patients. Br J Surg (1995) 1.19
Adenocarcinoma of the stomach: a multivariate analysis of clinical, pathologic and treatment factors. Hepatogastroenterology (1989) 1.18
Prognostic significance of the number of positive lymph nodes in gastric carcinoma. Br J Surg (1994) 1.17
Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma. Hepatogastroenterology (2002) 1.15
Comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage based on their location in patients with gastric cancer. J Clin Oncol (1993) 1.12
Lymph node micrometastasis in node negative early gastric cancer. Eur J Surg Oncol (2008) 1.11
Outcome of gastric cancer patients after successful gastrectomy: influence of the type of recurrence and histology on survival. Cancer (2006) 1.11
Is the new seventh AJCC/UICC staging system appropriate for patients with gastric cancer? J Am Coll Surg (2011) 1.11
Prognostic factors in patients with node-negative gastric carcinoma: a comparison with node-positive gastric carcinoma. World J Gastroenterol (2006) 1.10
Lymph nodes and gastric cancer. J Surg Oncol (2009) 1.10
Comparison of 6th and 7th AJCC TNM staging classification for carcinoma of the stomach in China. Ann Surg Oncol (2011) 1.10
Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer. J Gastrointest Surg (1999) 1.09
Significant prognostic factors in patients with early gastric cancer. Int Surg (2001) 1.09
Causes of death and recurrence after surgery for early gastric cancer. World J Surg (1997) 1.06
What is the problem in clinical application of sentinel node concept to gastric cancer surgery? J Gastric Cancer (2012) 1.06
A meta-analysis of D1 versus D2 lymph node dissection. Gastric Cancer (2011) 1.06
Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins. J Surg Oncol (2003) 1.05
Lymph node status assessment for gastric carcinoma: is the number of metastatic lymph nodes really practical as a parameter for N categories in the TNM Classification? Tumor Node Metastasis. J Surg Oncol (1998) 1.04
Prognostic impact of metastatic lymph node ratio on gastric cancer after curative distal gastrectomy. World J Gastroenterol (2010) 1.04
Ratio of metastatic to resected lymph nodes for prediction of survival in patients with inadequately staged gastric cancer. Br J Surg (2009) 1.03
An early gastric carcinoma treatment strategy based on analysis of lymph node metastasis. Cancer (1999) 1.03
Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg (2004) 1.03
Clinicopathologic characteristics and outcome indicators in node-negative gastric cancer. J Surg Oncol (2000) 1.02
Investigation of the recurrence patterns of gastric cancer following a curative resection. Surg Today (2011) 1.01
Prognostic significance of the number of metastatic lymph nodes in early gastric cancer. Dig Surg (2003) 1.00
Evaluation of the ratio of lymph node metastasis as a prognostic factor in patients with gastric cancer. Gastric Cancer (1999) 1.00
Minimum number of lymph nodes that should be examined for the International Union Against Cancer/American Joint Committee on Cancer TNM classification of gastric carcinoma. World J Surg (2003) 0.99
Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome. Ann Surg Oncol (2006) 0.99
Is D2 lymph node dissection necessary for early gastric cancer? Ann Surg Oncol (2002) 0.98
The new Japanese Classification of Gastric Carcinoma: Points to be revised. Gastric Cancer (1998) 0.96
General and specific prognostic factors of early gastric carcinoma treated with curative surgery. Hepatogastroenterology (1999) 0.95
Inadequate documentation and resection for gastric cancer in the United States: a preliminary report. Am Surg (1998) 0.95
Recurrent death among early gastric cancer patients: 20-years' experience. Hepatogastroenterology (1994) 0.94
The most appropriate category of metastatic lymph nodes to evaluate overall survival of gastric cancer following curative resection. J Surg Oncol (2008) 0.94
Analysis of 154 actual five-year survivors of gastric cancer. J Gastrointest Surg (2000) 0.93
Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer? Onkologie (2010) 0.92
Effect of negative lymph node count on survival for gastric cancer after curative distal gastrectomy. Eur J Surg Oncol (2011) 0.91
Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence. Can J Gastroenterol (2008) 0.90
Extended lymphadenectomy improvement of overall survival of gastric cancer patients with perigastric node metastasis. Langenbecks Arch Surg (2011) 0.89
Node-positive mucosal gastric cancer: a follow-up study. Jpn J Clin Oncol (2001) 0.87
Perigastric lymph node metastases in gastric cancer: comparison of different staging systems. Gastric Cancer (1999) 0.87
Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence. Hepatogastroenterology (2007) 0.87
[Prognostic factors in gastric cancer. Our experience and review of the literature]. Minerva Chir (2000) 0.85
Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer. Scand J Surg (2007) 0.85
First drainage lymph node(s) in gastric cancer: analysis of the topographical pattern of lymph node metastasis in patients with pN-1 stage tumors. Anticancer Res (2003) 0.84
[Multivariate prognostic analysis in gastric carcinoma patients after radical operation]. Ai Zheng (2005) 0.84
The prognostic analysis of lymph node-positive gastric cancer patients following curative resection. J Surg Res (2009) 0.84
Accurate lymph node staging is of greater prognostic importance than subclassification of the T2 category for gastric adenocarcinoma. Ann Surg Oncol (2003) 0.83
Efficacy of prophylactic extended lymphadenectomy with gastrectomy for patients with node-negative advanced gastric carcinoma. Hepatogastroenterology (2008) 0.83
Staging, stage migration, and patterns of spread in gastric cancer. Semin Radiat Oncol (2002) 0.82
Lymph node metastases in gastric cancer: correlation between new and old UICC TNM classification. Int Surg (2002) 0.82
Results of R0 surgery with D2 lymphadenectomy for the treatment of localised gastric cancer. Clin Transl Oncol (2009) 0.81
Over-DI dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients. Br J Cancer (2005) 0.81
D2 lymph node dissection improves staging in patients with gastric adenocarcinoma. Am Surg (2011) 0.80
Analysis of risk factors for the interval time, number and pattern of hepatic metastases from gastric cancer after radical gastrectomy. World J Gastroenterol (2008) 0.80
Clinicopathological evaluation of biological behavior of submucosal invasive gastric carcinomas: relationship among lymph node metastasis, mucin phenotype and proliferative activity. J Med Invest (2007) 0.79
Comparison of the UICC/AJCC 1992 and 1997 pN categories for gastric cancer patients after surgery. Hepatogastroenterology (2001) 0.79
Does the negative node count affect disease-free survival in early-stage oral cavity cancer? J Oral Maxillofac Surg (2009) 0.79
N stages of the seventh edition of TNM Classification are the most intensive variables for predictions of the overall survival of gastric cancer patients who underwent limited lymphadenectomy. Tumour Biol (2013) 0.79
Liver metastasis in gastric cancer with particular reference to lymphatic advancement. Gastric Cancer (2001) 0.78
Evaluation of endoscopic mucosal resection and nodal micrometastasis in pN0 submucosal gastric cancer. Oncol Rep (2005) 0.78